These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24653756)

  • 1. Phenotypic spectrum and hormonal profile in hypogonadotropic hypogonadism.
    Păun D; Gherlan I; Popescu I; Procopiuc C; Dumitrescu C; Brehar A; Dinu D; Neamtu C; Poiana C; Dumitrache C
    J Med Life; 2014 Mar; 7(1):42-5. PubMed ID: 24653756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal follicle-stimulating hormone and peak gonadotropin levels after gonadotropin-releasing hormone infusion show high diagnostic accuracy in boys with suspicion of hypogonadotropic hypogonadism.
    Grinspon RP; Ropelato MG; Gottlieb S; Keselman A; Martínez A; Ballerini MG; Domené HM; Rey RA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2811-8. PubMed ID: 20371659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
    Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) in hypogonadotropic hypogonadism with persistent azoospermia after hormonal therapy.
    Meseguer M; Garrido N; Remohí J; Pellicer A; Gil-Salom M
    J Assist Reprod Genet; 2004 Mar; 21(3):91-4. PubMed ID: 15202738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testicular gonadotropin receptors in men with hypogonadotropic hypogonadism.
    Namiki M; Kitamura M; Nonomura N; Nakamura M; Okuyama A; Sonoda T; Matsumoto K
    Arch Androl; 1988; 20(1):81-5. PubMed ID: 3133996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ; Hermanussen M; Sippell WG
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism.
    Ortac M; Hidir M; Salabas E; Boyuk A; Bese C; Pazir Y; Kadioglu A
    Asian J Androl; 2019; 21(6):623-627. PubMed ID: 31062720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism.
    Smals AG; Hermus AR; Boers GH; Pieters GF; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1994 Mar; 78(3):602-8. PubMed ID: 8126131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional delayed puberty in males and hypogonadotropic hypogonadism: a reliable and cost-effective approach to differential diagnosis.
    Martin MM; Martin AL
    J Pediatr Endocrinol Metab; 2005 Sep; 18(9):909-16. PubMed ID: 16279369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism.
    Kletter GB; Rolfes-Curl A; Goodpasture JC; Solish SB; Scott L; Henzl MR; Beitins IZ
    J Pediatr Endocrinol Metab; 1996; 9(1):9-19. PubMed ID: 8887129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients.
    Shoham Z; Balen A; Patel A; Jacobs HS
    Fertil Steril; 1991 Dec; 56(6):1048-53. PubMed ID: 1743320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center.
    Varimo T; Miettinen PJ; Känsäkoski J; Raivio T; Hero M
    Hum Reprod; 2017 Jan; 32(1):147-153. PubMed ID: 27927844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism and CHARGE association.
    Wheeler PG; Quigley CA; Sadeghi-Nejad A; Weaver DD
    Am J Med Genet; 2000 Sep; 94(3):228-31. PubMed ID: 10995509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism in hereditary hemochromatosis.
    McDermott JH; Walsh CH
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2451-5. PubMed ID: 15657376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis of ovarian dysgenesis and hypogonadotropic hypogonadism in women].
    Zarubina NA; Golubeva IV; Bobrovskaia TA; Konnova EV; Dobracheva AD
    Probl Endokrinol (Mosk); 1981; 27(1):45-9. PubMed ID: 6785737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum LH and FSH responses to the repetitive administration of gonadotropin-releasing hormone in patients with idiopathic hypogonadotropic hypogonadism.
    Reitano JF; Caminos-Torres R; Snyder PJ
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1035-42. PubMed ID: 1107344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB; Martin KA; Taylor E; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.